Toxoplasmosis

Front Matter....Pages I-XV
Front Matter....Pages 1-1
Allelic Polymorphyism in Toxoplasma Gondii Implications for Interstrain Mating....Pages 3-8
Study of Genetic Polymorphism of Toxoplasma Gondii Through Isoenzyme Analysis....Pages 9-17
Expression of Apical Organelles Antigens by a Toxoplasma Gondii Genomic Library....Pages 19-31
Dense Granule Antigens of Toxoplasma Gondii ....Pages 33-41
A Strategy for Cloning a DNA Polymerase Gene of Toxoplasma Gondii ....Pages 43-50
Extrachromosomal DNA in the Apicomplexa....Pages 51-60
Front Matter....Pages 61-61
Formation and Modification of the Parasitophorous Vacuole Occupied by Toxoplasma Gondii ....Pages 63-72
The Parasitophorous Vacuole Membrane Surrounding T. Gondii : A Specialized Interface Between Parasite and Cell....Pages 73-81
 Toxoplasma Gondii Motility and Invasion....Pages 83-92
 Toxoplasma Gondii : Patterns of Bradyzoite-Tachyzoite Interconversion In Vitro....Pages 93-98
The Growth and Development of Toxoplasma Gondii Tissue Cysts In Vitro ....Pages 99-108
Recent Advances in the Glycobiology of Toxoplasma Gondii ....Pages 109-121
Front Matter....Pages 123-123
Role of P30 in Attachment and Immunity to T. Gondii ....Pages 125-130
Secretory IgA, Antibody to SAG1 H-2 Class I-Restricted CD8 + T-Lymphocytes and the Int-1 Locus in Protection Against Toxoplasma Gondii ....Pages 131-151
Factors Responsible for Development of Toxoplasmic Enchephalitis in Immunocompromised Hosts....Pages 153-156
Synergistic and Compensatory Roles of CD4+, CD8+ T-Lymphocytes and Natural Killer Cells in Resistance to Toxoplasma Gondii ....Pages 157-162
Human T-Cell Clones as Tools to Identify Protective Antigens of Toxoplasma Gondii ....Pages 163-168
Protection of Mice and Nude Rats Against Toxoplasmosis by an Octameric Construct of the P30 48–67 Peptide....Pages 169-177
Front Matter....Pages 179-179
Synergistic Drug Combinations in the Treatment of Toxoplasmosis....Pages 181-190
 Toxoplasma Gondii : Chemotherapy....Pages 191-198
Front Matter....Pages 179-179
Diagnosis of Toxoplasma Gondii Infections by Molecular Detection....Pages 199-207
Use of Toxoplasma Gondii Recombinant Antigens for Diagnosis and Seroepidemiology....Pages 209-215
Progress Towards the Development of a Vaccine Against Congenital Toxplamosis: Identification of Protective Antigens and the Selection of Appropriate Adjuvants....Pages 217-229
Development of a Live Vaccine Against Ovine Toxoplasmosis....Pages 231-243
Genetic Regulation of Toxoplasma Gondii Infection: Influence of LSH/ITY/BCG Gene....Pages 245-246
Establishing a Laboratory for Parasite Genome Analysis: Focus on the Parasitic Protozoa Toxoplasma, Trypanosoma and Leishmania ....Pages 246-247
Mucosal Immune Response in Toxoplasmosis....Pages 247-248
Antenatal Screening for Toxoplasmosis in Turkiye....Pages 248-249
Toxoplasmosis in Greece: Serological Studies....Pages 249-250
Critical Evaluation of IGA Antibodies as an Indication of Early Toxoplasma-Infection....Pages 250-251
Expression of Toxoplasma Gondii Genes in rBCG....Pages 251-252
Back Matter....Pages 253-258